ArticleChemistry and physics of lipids2015
Helix 1 tryptophan variants in Galleria mellonella apolipophorin III.
Article in Chemistry and physics of lipids, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 4 citations in OpenAlex.
- Regulatory networks of mRNAs and miRNAs involved in the immune response of diamondback moth, Plutella xylostella to fungal infection.BMC genomics · 2025Article
- Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.Frontiers in immunology · 2020Review
- Lipid-bound apoLp-III is less effective in binding to lipopolysaccharides and phosphatidylglycerol vesicles compared to the lipid-free protein.Molecular and cellular biochemistry · 2019Article
- Deletion of the N- or C-Terminal Helix of Apolipophorin III To Create a Four-Helix Bundle Protein.Biochemistry · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Apolipophorin III (apoLp-III) from Galleria mellonella is a critical apolipoprotein aiding in lipid transport and has gained considerable interest for a role in innate immunity. Both functions are likely related and form the rationale to gain a more detailed understanding of the lipid binding properties of this insect apolipoprotein. Tryptophan residues were introduced at positions 16, 20 or 24, all in helix 1 as it may play a critical role in the initial steps of lipid binding. Steady-state fluorescence analysis showed that each tryptophan displayed unique properties, indicating different environments both in lipid-free as in lipid-bound states, and demonstrating potential for use in lipid binding analysis. While α-helical contents of wild-type and the tryptophan variant proteins were similar, W20- and W24-apoLp-III displayed increased protein stability. These variants were significantly slower in their ability to convert phosphatidylcholine vesicles into discoidal lipoproteins, which was employed as a measure for lipid binding. In contrast, W16-apoLp-III displayed decreased protein stability but an order of magnitude higher rate of discoidal lipoprotein formation. This demonstrates an inverse correlation between protein stability and the ability to convert vesicles in discoidal lipoproteins. The most stable W20-apoLp-III variant displayed comprised LDL binding capabilities, indicating a partial loss of function. Thus, there is a delicate balance between helix bundle stability and the ability to bind lipids, and helix 1 may play a critical role in this process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.